Research Unit

Ghent Research Group on Nanomedicines

Acronym
GeRN
Duration
19 April 2019 → Ongoing
Group leader
Research disciplines
  • Engineering and technology
    • Nanobiotechnology
    • Nanophotonics
Description
The Ghent Research Group on Nanomedicines (GeRN), headed by prof. Stefaan De Smedt, focuses on the design and evaluation of nanomedicines for the advanced delivery of biotherapeutics (especially nucleic acid based drugs).